Canada’s abundance of clinical data – combined with its expertise in AI – are poised to drive profound changes in the diagnosis and treatment of diseases like cancer and Alzheimer’s.
Article Type: Generic
Over $53M in new funding for cancer research in Quebec
The promise of personalized medicine, fueled by next-gen technologies like artificial intelligence, are driving major new investments in cancer research in Quebec.
Ontario innovation hubs join forces on new scale-up platform, despite provincial funding cuts
The federal government’s $52.4M investment allows hubs to offer joint programs and services to support scaleups
Implementation of Europe’s ambitious open-access plan postponed
The start date for Plan S, a Europe-led vision to make full and immediate open-access to publicly funded research a reality, has been postponed by a year to January 1, 2021, in response to public feedback.
CDRD and NEOMED merge to create a pan-Canadian life sciences powerhouse
Research institutes combine funding, expertise, talent and facilities to create adMare BioInnovations
Ontario Budget 2019 takes “slice-and-dice” strategy to research funding
Ontario budget cuts more than $300 million in research and innovation funding
BC life science powerhouses partner to commercialize targeted cancer therapies
A first-ever collaboration between CDRD and Triumf could put Canada on the fast track for tackling late stage cancer.
Canada’s lopsided innovation policy needs greater focus on industry uptake of technology: Study
Canada is stuck in “a supply-side policy silo” that stifles innovation: IRPP study
CIHR and partners invest $24.5M to study cannabis
The Canadian Institutes of Health Research and partners are investing $24.5 million to explore the health risks and benefits of cannabis.
Tri-council exploring new mechanisms to promote interdisciplinary research
The tri-council granting agencies are determined to support more interdisciplinary research. But there are still several barriers to overcome before this can happen.